Adrenal incidentaloma
M Sherlock, A Scarsbrook, A Abbas, S Fraser… - Endocrine …, 2020 - academic.oup.com
An adrenal incidentaloma is now established as a common endocrine diagnosis that
requires a multidisciplinary approach for effective management. The majority of patients can …
requires a multidisciplinary approach for effective management. The majority of patients can …
miRNAs orchestration of adrenocortical carcinoma-Particular emphasis on diagnosis, progression and drug resistance
WA El-Dakroury, HM Midan, AI Abulsoud… - … -Research and Practice, 2023 - Elsevier
Adrenocortical carcinoma (ACC) is an uncommon aggressive endocrine malignancy that is
nonetheless associated with significant mortality and morbidity rates because of endocrine …
nonetheless associated with significant mortality and morbidity rates because of endocrine …
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the …
M Fassnacht, S Tsagarakis, M Terzolo… - European Journal of …, 2023 - academic.oup.com
Adrenal incidentalomas are adrenal masses detected on imaging performed for reasons
other than suspected adrenal disease. In most cases, adrenal incidentalomas are …
other than suspected adrenal disease. In most cases, adrenal incidentalomas are …
Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology
MH Shah, WS Goldner, AB Benson… - Journal of the National …, 2021 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine
and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients …
and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients …
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Fassnacht, G Assie, E Baudin… - Annals of …, 2020 - annalsofoncology.org
Two different primary malignancies can arise from the adrenal gland: adrenocortical
carcinoma (ACC) from the adrenal cortex and malignant phaeochromocytoma from the …
carcinoma (ACC) from the adrenal cortex and malignant phaeochromocytoma from the …
Treatment of Cushing's syndrome: an endocrine society clinical practice guideline
LK Nieman, BMK Biller, JW Findling… - The Journal of …, 2015 - academic.oup.com
Objective: The objective is to formulate clinical practice guidelines for treating Cushing's
syndrome. Participants: Participants include an Endocrine Society-appointed Task Force of …
syndrome. Participants: Participants include an Endocrine Society-appointed Task Force of …
[HTML][HTML] Comprehensive pan-genomic characterization of adrenocortical carcinoma
We describe a comprehensive genomic characterization of adrenocortical carcinoma (ACC).
Using this dataset, we expand the catalogue of known ACC driver genes to include …
Using this dataset, we expand the catalogue of known ACC driver genes to include …
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
Background Cross-sectional imaging regularly results in incidental discovery of adrenal
tumours, requiring exclusion of adrenocortical carcinoma (ACC). However, differentiation is …
tumours, requiring exclusion of adrenocortical carcinoma (ACC). However, differentiation is …
The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma-A focus on signaling pathways interplay
Adrenocortical carcinoma (ACC) is a highly malignant infrequent tumor with a dismal
prognosis. microRNAs (miRNAs, miRs) are crucial in post-transcriptional gene expression …
prognosis. microRNAs (miRNAs, miRs) are crucial in post-transcriptional gene expression …
Cushing's syndrome
Chronic exposure to excess glucorticoids results in diverse manifestations of Cushing's
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …